Merck EPS - Earnings per Share 2012-2026 | MRK

Merck earnings per share (EPS) for the twelve months ending March 31, 2026 was $3.55, a 48.4% decline year-over-year.

  • Merck EPS for the quarter ending March 31, 2026 was $-1.72, a 185.57% decline year-over-year.
  • Merck 2025 annual EPS was $7.28, a 8.01% increase from 2024.
  • Merck 2024 annual EPS was $6.74, a 4714.29% increase from 2023.
  • Merck 2023 annual EPS was $0.14, a 97.55% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Merck EPS - Earnings per Share 2012-2026 | MRK

  • Merck EPS for the quarter ending March 31, 2026 was $-1.72, a 185.57% decline year-over-year.
  • Merck 2025 annual EPS was $7.28, a 8.01% increase from 2024.
  • Merck 2024 annual EPS was $6.74, a 4714.29% increase from 2023.
  • Merck 2023 annual EPS was $0.14, a 97.55% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B